Clinical trial
Silent Brain Infarcts in Spontaneous Intracerebral Hemorrhage as a Prognostic Biomarker for Vascular Contributions to Cognitive Impairment and Dementia (VCID)
NCT06836141 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Silent Brain Infarcts in Spontaneous Intracerebral Hemorrhage as a Prognostic Biomarker for Vascular Contributions to Cognitive Impairment and Dementia (VCID)
- Lead sponsor
- Rush University Medical Center
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- August 2, 2025
- Completion date
- August 1, 2029
- Enrollment
- 118 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
primary intracerebral hemorrhage